CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100

CVS Health Corporation 10-K filed Feb 10, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 6:36 AM ET · Document on sec.gov · Filing index

What changed

Item 1A, Risk Factors, against the 10-K filed Feb 12, 2025: 10 added · 50 removed · 108 modified; 1 with only figures updated; 14 moved without change

168 more changes in this Item, word by word, in Powerpack.

Powerpack